Abiopharma

🔍 Mayson Howard John (Executive)

Company: Ovintiv Inc. (OVV)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 48 shares of Deferred Share Unit (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 10,028.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1

Footnotes:

• F1: Each Deferred Share Unit ("DSU") is the economic equivalent of one share of common stock of Ovintiv Inc. and yields dividend equivalent DSUs. DSUs are held until retirement from the Board.
• F2: Dividend equivalent DSUs received in lieu of cash dividends for the first quarter of 2026.